29 results found.

Neoplasm Malignant Clinical Trial using SAR245408; SAR245409

Sanofi - Recruiting N/A or older.
- International, Multicenter, Open-label, Treatment-extension Study for Subjects Who Completed a Phase 1 or Phase 2 Parental Study to Continue Receiving Treatment With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen.
SAR245408; SAR245409

Malignant Neoplasm Clinical Trial using computer-assisted intervention; Standard educational information

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- Tailoring Patient Education to Perceived Risk for Falls in Hospitalized Oncology Patients: A Pilot Study.
computer-assisted intervention; Standard educational information

Malignant Neoplasm Clinical Trial using fluorine F 18 d-FMAU; positron emission tomography; computed tomography

University of Southern California - Recruiting 19 years or older.
- 18F-FMAU for Imaging in Cancer Patients.
fluorine F 18 d-FMAU; positron emission tomography; computed tomography

Pancreatic Cancer, Pancreatic Carcinoma Non-resectable, or Locall Clinical Trial using FOLFIRINOX; Algenpantucel-L Immunotherapy; 5-FU Chemoradiation; Gemcitabine; Capecitabine; Nab-Paclitaxel

NewLink Genetics Corporation - Recruiting 18 years or older.
- A Phase III Study of Chemotherapy With or Without Algenpantucel-L (HyperAcuter-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
FOLFIRINOX; Algenpantucel-L Immunotherapy; 5-FU Chemoradiation; Gemcitabine; Capecitabine; Nab-Paclitaxel

Hemangioblastoma, Hereditary Neoplastic Syndrome, Hippel Lindau D Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders.

Neoplasm Malignant Clinical Trial using SAR566658

Sanofi - Recruiting 18 years or older.
- Dose Escalation, Safety and Pharmacokinetic, First in Man Study, of SAR566658 Administered as a Single Agent by Intravenous Infusion Every 3 Weeks in Adult Patients With CA6-Positive and Refractory Solid Tumors.
SAR566658

Malignant Neoplasm Clinical Trial using music therapy; caregiver-related intervention or procedure; questionnaire administration; quality-of-life assessment

Children's Oncology Group - Recruiting 11 years to 24 years.
- Music Video for AYA-Parent Communication and Resilience.
music therapy; caregiver-related intervention or procedure; questionnaire administration; quality-of-life assessment

Neoplasm Malignant Clinical Trial using Cabazitaxel (XRP6258)

Sanofi - Recruiting 18 years or older.
- Phase I Safety and Pharmacokinetic Study of XRP6258 (Cabazitaxel) In Advanced Solid Tumor Patients With Varying Degrees of Hepatic Impairment.
Cabazitaxel (XRP6258)

Leukemia, Lymphoid Malignancies, or Metastatic Malignant Neoplasm Clinical Trial using Intrathecal Rituximab

M.D. Anderson Cancer Center - Recruiting 3 years or older.
- Safety and Efficacy of Intrathecal Rituximab in Patients With Lymphoid Malignancies Involving the Central Nervous System.
Intrathecal Rituximab

Anorexia, Cachexia, Malignant Neoplasm, or Oral Complications of Clinical Trial using bovine lactoferrin supplement; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis

Comprehensive Cancer Center of Wake Forest University - Recruiting 18 years or older.
- A Pilot Study of Bovine Lactoferrin in Cancer Patients Reporting Taste Disturbances While Receiving Chemotherapy.
bovine lactoferrin supplement; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis

Malignant Neoplasm, or Psychosocial Effects of Cancer and Its Tre Clinical Trial using psychosocial assessment and care; educational intervention; communication skills training; questionnaire administration

City of Hope Medical Center - Recruiting 18 years to 30 years.
- Pilot Study of Psycho-Educational Group for Young Adults (YA) on Treatment: Impact on Knowledge, Distress, and Satisfaction.
psychosocial assessment and care; educational intervention; communication skills training; questionnaire administration

Neoplasm Malignant Clinical Trial using SAR405838; Pimasertib

Sanofi - Recruiting 18 years or older.
- A Phase 1 Study of Combination Therapy With SAR405838 and Pimasertib in Patients With Advanced Cancer.
SAR405838; Pimasertib

IPMN Clinical Trial

Asan Medical Center - Recruiting 20 years or older.
- Intraductal Papillary Mucinous Neoplasm (IPMN) With Malignant Change: Prospective Study to Assess Diagnostic Performance of CT and Magnetic Resonance Imaging (MR) According to International Consensus Guidelines 2012.

Neoplasm Malignant Clinical Trial using SAR405838

Sanofi - Recruiting 18 years or older.
- A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Biological Activity of SAR405838 in Patients With Advanced Cancer.
SAR405838

Lymphedema, or Malignant Neoplasm Clinical Trial using recombinant human hyaluronidase; laboratory biomarker analysis; pharmacological study

Stanford University - Recruiting N/A or older.
- Pilot Phase I/II Investigational Study to Assess the Efficacy and Safety of Recombinant Hyaluronidase (rHUPH20) in the Treatment of Secondary Lymphedema Resulting From Local Management of Malignancy.
recombinant human hyaluronidase; laboratory biomarker analysis; pharmacological study

Neoplasm Malignant Clinical Trial using SAR245409

Sanofi - Recruiting 18 years or older.
- A Phase 1 Dose-escalation Study of the Safety and Pharmacokinetics of a Tablet Formulation of SAR245409 Administered Daily to Patients With Solid Tumors or Lymphoma.
SAR245409

Malignant Female Reproductive System Neoplasm Clinical Trial using Enoxaparin, Heparin

National Guard Health Affairs - Recruiting 18 years or older.
- A Randomized, Controlled, Open Label Study of the Efficacy and Safety of the Low Molecular Weight Heparin (LMWH), LovenoxTM (Enoxaparin) Versus HeparinTM (Unfractionated Heparin) for Prevention of Venous Thromboembolism (VTE) in Gynecologic Oncology Patients.
Enoxaparin, Heparin

Neoplasm Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease.

Malignant Solid Tumor - Malignant Nervous System Neoplasm Clinical Trial using Cabazitaxel (XRP6258)

Sanofi - Recruiting 2 years to 18 years.
- A Phase 1-2 Dose Finding, Safety and Efficacy Study of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Tumors of the Central Nervous System.
Cabazitaxel (XRP6258)

Malignant Neoplasm of Breast, CNS Malignancy, Malignant Neoplasm Clinical Trial using Alisertib; Pazopanib

University of Illinois at Chicago - Recruiting 18 years or older.
- Phase I Study of Aurora A Kinase Inhibitor (MLN8237) Given in Combination With Selective VEGFR Inhibitor Pazopanib (Votrient) for Therapy in Solid Tumors.
Alisertib; Pazopanib

Malignant Neoplasm Clinical Trial using Total-body irradiation; Donor lymphocytes infusion (DLI); Cyclophosphamide; Allogeneic hematopoietic stem cell transplantation (HSCT); Tacrolimus; Mycophenolate mofetil

Thomas Jefferson University - Recruiting 18 years or older.
- A Two Step Approach to Haploidentical Hematopoietic Stem Cell Transplantation for Patients in Remission From HLA Partially-Matched Related Donors-Effect of Maternal Donors on Outcomes.
Total-body irradiation; Donor lymphocytes infusion (DLI); Cyclophosphamide; Allogeneic hematopoietic stem cell transplantation (HSCT); Tacrolimus; Mycophenolate mofetil

Colon Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Malign Clinical Trial using magnetic resonance imaging with positron emission tomography scanning

Case Comprehensive Cancer Center - Recruiting N/A or older.
- Evaluating Attenuation Correction Methods Applied to PET/MRI.
magnetic resonance imaging with positron emission tomography scanning

Secondary Malignant Neoplasm of Vertebral Column Clinical Trial

AOSpine International - Recruiting 18 years to 75 years.
- The Epidemiology, Process and Outcomes of Spine Oncology.

Brain Tumor, or Malignant Neoplasm of Fourth Ventricle of Brain Clinical Trial using Ommaya Reservoir; Methotrexate; Leucovorin

M.D. Anderson Cancer Center - Recruiting N/A to 22 years.
- Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study.
Ommaya Reservoir; Methotrexate; Leucovorin

Breast Cancer, or Locally Advanced Malignant Neoplasm Clinical Trial using Cholecalciferol; Inj. Progesterone; Doxyrubicin or Epirubicin

Tata Memorial Hospital - Recruiting 18 years to 70 years.
- Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With LOBC and LABC - A Feasibility Study.
Cholecalciferol; Inj. Progesterone; Doxyrubicin or Epirubicin

Secondary Malignant Neoplasm of Liver, or Colorectal Neoplasms Clinical Trial using Open liver resection; Laparoscopic liver resection

Oslo University Hospital - Recruiting 18 years or older.
- Prospective Randomized Study of Laparoscopic Versus Open Liver Resection for Colorectal Metastases.
Open liver resection; Laparoscopic liver resection

Locally Advanced Malignant Neoplasm, Oral Cancer, or Oropharyngea Clinical Trial using Neo-adjuvant Erbitux-based chemotherapy

Shanghai Jiao Tong University School of Medicine - Recruiting 18 years to 75 years.
- Neo-adjuvant Erbitux-based Chemotherapy Followed by Surgery and Radiotherapy for Locally Advanced Oral/Oropharyngeal Cancer.
Neo-adjuvant Erbitux-based chemotherapy

GLIOBLASTOMA MULTIFORME, or Brain Neoplasm Clinical Trial

Washington University School of Medicine - Recruiting 18 years to 70 years.
- BIRN (Biomedical Informatics Research Network)Resources Facilitate the Personalization of Malignant Brain Tumor.

Breast Neoplasms, Neoplasm Metastasis, Gene Expression Profiling, Clinical Trial using cytokine

Beijing Cancer Hospital - Recruiting 18 years to 75 years.
- Gene Expression Profiling of Breast Cancer Cells in Pleural Effusion Prodict the Response of Malignant Pleural Effusion to Immunotherapy.
cytokine